Seminars in Nuclear Medicine
Volume 29, Issue 2 , Pages 128-145 , April 1999

Interventions in renal scintirenography

  • Eugene J. Fine

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Eugene J. Fine, MD, Jacobi Medical Center, Department of Nuclear Medicine, Pelham Parkway and Eastchester Road, Bronx, NY 10461.

References 

  1. Fine EJ. Interventions in renal scintirenography. Semin Nucl Med. 1991;21:116–127
  2. Stadalnik AJ, Vogel JM, Jansholt A, et al. Renal clearance and extraction parameters of ortho-iodohippurate (I-123) compared with ortho-iodohippurate (I-131) and para-aminohippurate. J Nucl Med. 1980;21:168–170
  3. Fritzberg AR, Kasina S, Eshima D, et al. Synthesis and biological evaluation of technetium-99m MAG 3 as a hippuran replacement. J Nucl Med. 1986;27:111–116
  4. Klopper JF, Hause W, Atkins HL, et al. Evaluation of 99mTc-DTPA for the measurement of glomerular filtration. J Nucl Med. 1971;13:107–110
  5. Klahr S, Buerkert J, Morrison A. Urinary tract obstruction. In: Brenner BM, Rector FC editor. The kidney. ed 3. Philadelphia, PA: Saunders; 1986;p. 1443
  6. Whitaker RH. An evaluation of 170 diagnostic pressure flow studies of the upper urinary tract. J Urol. 1979;121:602
  7. O'Reilly PH, Testa HJ, Lawson RS, et al. Diuresis renography in equivocal urinary tract obstruction. Br J Urol. 1978;50:76–80
  8. Koff SA, Thrall JH, Keyes JW. Diuretic radionuclide urography: a non-invasive method for evaluating nephroureteral dilatation. J Urol. 1979;122:451
  9. O'Reilly P. Consensus on diuresis renography for investigating the dilated upper urinary tracy. J Nucl Med. 1996;37:1872–1876
  10. Society for Fetal Urology and The Pediatric Nuclear Medicine Council . The “well tempered” diuretic renogram: a standard method to examine the asymptomatic neonate with hydronephrosis or hydroureteronephrosis. The Society of Nuclear Medicine. J Nucl Med. 1992;33:2047–2051
  11. Mandell GA, Cooper JA, Leonard JC, et al. Procedure guideline for diuretic renography in children. J Nucl Med. 1997;38:1647–1650
  12. O'Reilly PH. Diuresis renography 8 years later: an update. J Urol. 1986;136:993–999
  13. English PH, Testa HJ, Shields RA, et al. Modified method of diuresis renography for the assessment of equivocal pelviureteral junction obstruction. Br J Urol. 1987;59:10–14
  14. Koff SA, McDowell GC, Byard M. Diuretic radionuclide assessment of obstruction in the infant: guidelines for successful interpretation. J Urol. 1988;140:1167–1168
  15. Wong JCH, Rossleigh A, Farnsworth RH. Utility of Technetium-99m-MAG3 diuretic renography in the neonatal period. J Nucl Med. 1995;36:2214–2219
  16. Itoh K, Taniguchi K, Nantani M, et al. Comparison of conventional furosemide diuresis renography with direct intrapelvic infusion renography. In: Blaufox MD, Hollenberg NK, Raynaud C editor. Radionuclides in nephro-urology. Contrib Nephrol. 79:1990;p. 156–160
  17. Lupton EW, Rickards D, Testa HJ, et al. A comparison of diuresis renography, the Whitaker test and renal pelvic morphology in idiopathic hydronephrosis. Br J Urol. 1984;57:119
  18. Kass EJ, Majd M, Belman AB. Comparison of the diuretic renogram and the pressure perfusion study in children. J Urol. 1985;134:92–96
  19. Lupton EW, Testa HJ, O'Reilly , et al. Diuresis renography and morphology in upper urinary tract obstruction. Br J Urol. 1979;51:10
  20. Tubis M, Posnick E, Nordyke RA. Preparation and use of I-131 labelled sodium iodohippurate in kidney function tests. In: Proc Soc Exp Biol Med. 109:1960;p. 497–498
  21. McNeil BJ, Varady PD, Burrows BA, Adelstein SJ. Measures of clinical efficacy. Cost-effectiveness calculations in the diagnosis and treatment of hypertensive renovascular disease. N Engl J Med. 1975;293:216–221
  22. Fine EJ, Scharf SC, Blaufox MD. The role of nuclear medicine in evaluating the hypertensive patient. In: Freeman LM, Weissman HS editor. Nuclear medicine annual. New York, NY: Raven; 1984;p. 23–79
  23. Lewin A, Blaufox MD, Castle H, et al. Apparent prevalence of curable hypertension in the hypertension detection and follow-up program. Arch Intern Med. 1985;145:424–427
  24. Majd M, Potter BM, Guzzetta PC, et al. Effect of captopril on efficacy of renal scintigraphy in detection of renal artery stenosis (abstract). J Nucl Med. 1983;24:23
  25. Lee HB, Blaufox MD. Renal functional changes after angiotensin converting enzyme inhibition or nitroprusside in hypertensive rats (suppl 5). J Hypertens. 1986;4:S266–S268
  26. Nally JV, Clarke HS, Grecos GP, et al. Effect of captopril on Tc99m-diethylene triamine pentaacetic acid renograms in two-kidney, one clip hypertension. Hypertension. 1986;8:685–693
  27. Lee HB, Blaufox MD. Technetium-99m MAG-3 clearances after captopril in experimental renovascular hypertension. J Nucl Med. 1989;30:666–671
  28. Kopecky RT, McAfee JG, Thomas FD, et al. Enalaprilatenhanced renography in a rat model of renovascular hypertension. J Nucl Med. 1990;31:501–507
  29. Taylor A, Eshima D. Renal artery stenosis and ischemia: effect on renal blood flow and extraction fraction. Hypertension. 1994;23:96–103
  30. Hall JE, Guyton AC, Jackson RE, et al. Control of glomerular filtration rate by renin angiotensin system (suppl 5). Am J Physiol. 1977;233:F366–F372
  31. Setaro JF, Saddler MC, Chen CC, et al. Simplified captopril renography in diagnosis and treatment of renal artery stenosis. Hypertension. 1991;18:289–298
  32. Fommei E, Ghione S, Hilson AJW, et al. Captopril radionuclide test in revovascular hypertension: European multicentre study. Eur J Nucl Med. 1993;20:617–623
  33. Dondi M, Monetti N, Fanti S, et al. Use of Technetium-99m-MAG3 for renal scintigraphy after angiotensin-converting enzyme inhibition. J Nucl Med. 1991;32:424–428
  34. Sfakianakis GN, Bourgoignie JJ, Jaffe D, et al. Single dose captopril scintigraphy in the diagnosis of renovascular hypertension. J Nucl Med. 1987;28:1383–1392
  35. Dondi M, Franchi R, Levorato M, et al. Evaluation of hypertensive patients by captopril-enhanced renal scintigraphy with technetium-99m DTPA. J Nucl Med. 1989;30:615–621
  36. Mann SJ, Pickering TG, Sos TA, et al. Captopril renography in the diagnosis of artery stenosis: Accuracy and limitations. Am J Med. 1991;90:30–40
  37. Miyamori I, Yasuhara S, Takeda Y, et al. Effects of converting enzyme inhibition on split renal function in renovascular hypertension. Hypertension. 1986;8:415–421
  38. Roccatello D, Picciotto G, Rabbia C, et al. Prospective study on captopril renography in hypertensive patients. Am J Nephrol. 1992;12:406–411
  39. Blaufox MD, Fine EJ, Heller S, et al. Prospective study of simultaneous orthoiodohippurate and diethylenetriaminepentaacetic acid captopril renography. J Nucl Med. 1998;39:522–528
  40. Vidt DG, Bravo EL, Fouad FM. Captopril. N Engl J Med. 1982;306:214–219
  41. Wenting GJ, Tan-Tjiong HL, Dereks FHM, et al. Split renal function after captopril in unilateral renal artery stenosis. Br J Med. 1984;288:886–890
  42. Taylor A, Nally J, Aurell M, et al. Consensus report on ACE inhibitor renography for detecting renovascular hypertension. J Nucl Med. 1996;37:1876–1882
  43. Nally JV, Chen C, Fine E, et al. Diagnostic criteria of renovascular hypertension with captopril renography: a consensus statement. Am J Hypertens. 1991;4:749S–752S
  44. Taylor AT, Fletcher JW, Nally JV, et al. Procedure guideline for diagnosis of renovascular hypertension. J Nucl Med. 1998;39:1297–1302
  45. Blaufox MD, Middleton ML, Bongiovanni J, Davis BR. Cost efficacy of the diagnosis and therapy of renovascular hypertension. J Nucl Med. 1996;37:171–177
  46. Setaro JF, Chen CC, Hoffer PB, Black HR. Captopril renography in the diagnosis of renal artery stenosis and the prediction of improvement with revascularization. (The Yale Vascular Center Experience). Am J Hypertens. 1991;4:698S–705S
  47. Geyskes GG, DeBruyn AJG. Captopril renography and the effect of percutaneous transluminal angioplasty on blood pressure in 94 patients with renal artery stenosis. Am J Hypertens. 1991;4:685S–689S
  48. Dondi M, Fanti S, DeFabritiis A, et al. Prognostic value of captopril renal scintigraphy in renovascular hypertension. J Nucl Med. 1992;33:2040–2044
  49. Henrich WL. Role of prostaglandins in renin secretion. Kidney Intl. 1981;19:822–830
  50. Imanishi M, Kawamura M, Akabane S, et al. Aspirin lowers blood pressure in patiens with renovascular hypertension. Hypertension. 1989;14:461–468
  51. DeKlerk JMH, Beutler JJ, van Isselt JW, et al. Aspirin versus captopril renography in the diagnosis of renal artery stenosis (5 suppl). J Nucl Med. 1996;289P:
  52. Goldblatt H, Lynch J, Hanzal RF, et al. Studies on experimental hypertension. 1. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59:347–379
  53. Bianchi G, Fox U, Di Francesco GF, et al. Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med. 1974;47:435–448
  54. Dahl LK, Heine M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res. 1975;36:692–696
  55. Curtis JJ, Luke RG, Dustan HP, et al. Remission of essential hypertension after renal transplantation. N Engl J Med. 1983;309:1009–1015
  56. Guyton AC, Coleman TG, Cowley AW, et al. Arterial pressure regulation, overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med. 1972;52:584–594
  57. Hollenberg NK, Borucki LJ, Adams DF. The renal vasculature in early essential hypertension: evidence for pathogenic role. Medicine. 1978;57:161–178
  58. Gruenewald SM, Nimmon CC, Nawaz MK, et al. A non-invasive gamma camera technique for the measurement of intrarenal flow distribution in man. Clin Sci. 1981;61:385–389
  59. Case DB, Casarella WJ, Laragh JH, et al. Renal cortical blood flow and angiography in low and normal renin essential hypertension. Kidney Int. 1978;13:236–244
  60. Hollenberg NK, Epstein M, Basch RI, Merrill JP. No mans land of the renal vasculature. Am J Med. 1969;47:845–854
  61. Britton KE. The measurement of intrarenal flow distribution in man. Clin Sci. 1979;56:101–104
  62. Sommers SC, Relman AS, Smithwick RH. Histologic studies of kidney biopsy specimens from patients with hypertension. Am J Pathol. 1958;34:685–715
  63. Laragh JH, Baer L, Brunner HR, et al. Renin, angiotensin, and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med. 1972;52:633–649
  64. Sealey JE, Blumenfeld JD, Bell GM, et al. Nephron heterogeneity with unsuppressible renin secretion: a cause of essential hypertension. In: Baragh JH, Brenner BM editor. Hypertension: pathophysiolgy, diagnosis, and management. 2nd ed. New York, NY: Raven Press; 1995;p. 1405
  65. Britton KE. Essential hypertension: a disorder of cortical nephron control?. Lancet. 1981;2:900–903
  66. Crum CE, Luft FC, Fineberg MS, et al. Responses to volume expansion and constriction in categorized hypertensive and normotensive man. Hypertension. 1979;1:476–485
  67. Luft FC, Grim CE, Willis LR, et al. Natriuretic response to saline infusion in normotensive and hypertensive man. The role of renin suppression in exaggerated natriuresis. Circulation. 1977;55:779–784
  68. Britton KE, Brown NJG. Clinical renography. In: London: England, Lloyd Luke; 1971;p. 207–219
  69. Britton KE. The measurement of intrarenal flow distribution in man. Clin Sci. 1979;56:101–104
  70. Clorius JH, Schmidlin P. The exercise renogram: a new approach documents renal involvement in systemic hypertension. J Nucl Med. 1983;24:104–109
  71. Clorius JH, Allenberg J, Hupp T, et al. Predictive value of exercise renography for presurgical evaluation of nephrogenic hypertension. Hypertension. 1987;10:280–286
  72. Fine EJ, Blaufox MD, Blumenfeld JD, et al. Exercise renography in untreated subjects with essential hypertension. J Nucl Med. 1996;37:838–842
  73. 87P Fanti S, Dondi M, Galassi R, et al. Exercise renography in supine position in hypertensive patients (suppl). J Nucl Med. 1998;39:
  74. Bucht HJEK, Eliasch H, Holmgren A, et al. The effect of exercise in the recumbent position on renal circulation and sodium excretion in normal individuals. Acta Physiol Scand. 1953;28:95–100
  75. Clorius JH, Reinhold F, Hupp T, et al. Renovascular hypertension: a perfusion disturbance that escaped recognition. J Nucl Med. 1993;34:48–56
  76. Rosenthall L, Tyler JL, Arzoumanian A. A cross-over study comparing delayed radiohippurate images with furosemide renograms. Diagn Imag. 1983;52:267–275
  77. Conway JJ, King LR, Belman AB, et al. Detection of vesicoureteral reflux in radionuclide cystography: a comparison study with roentgenographic cystography. Am J Roentgen Radium Ther Nucl Med. 1972;115:720–727
  78. Case DB, Laragh JH. Reactive hyperreninemia following angiotensin blockade with either saralasin or converting enzyme inhibitor: a new approach to screen for renovascular hypertension. Ann Intern Med. 1979;91:153–160

PII: S0001-2998(99)80004-X

Seminars in Nuclear Medicine
Volume 29, Issue 2 , Pages 128-145 , April 1999

Article Tools